An Alternative to Antibodies in the Detection of Molecular Biomarkers

Michaela Domsicova,Jana Korcekova,Alexandra Poturnayova,Albert Breier
DOI: https://doi.org/10.3390/ijms25136833
IF: 5.6
2024-06-22
International Journal of Molecular Sciences
Abstract:Aptamers are short oligonucleotides with single-stranded regions or peptides that recently started to transform the field of diagnostics. Their unique ability to bind to specific target molecules with high affinity and specificity is at least comparable to many traditional biorecognition elements. Aptamers are synthetically produced, with a compact size that facilitates deeper tissue penetration and improved cellular targeting. Furthermore, they can be easily modified with various labels or functional groups, tailoring them for diverse applications. Even more uniquely, aptamers can be regenerated after use, making aptasensors a cost-effective and sustainable alternative compared to disposable biosensors. This review delves into the inherent properties of aptamers that make them advantageous in established diagnostic methods. Furthermore, we will examine some of the limitations of aptamers, such as the need to engage in bioinformatics procedures in order to understand the relationship between the structure of the aptamer and its binding abilities. The objective is to develop a targeted design for specific targets. We analyse the process of aptamer selection and design by exploring the current landscape of aptamer utilisation across various industries. Here, we illuminate the potential advantages and applications of aptamers in a range of diagnostic techniques, with a specific focus on quartz crystal microbalance (QCM) aptasensors and their integration into the well-established ELISA method. This review serves as a comprehensive resource, summarising the latest knowledge and applications of aptamers, particularly highlighting their potential to revolutionise diagnostic approaches.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper aims to explore the application of aptamers in the detection of molecular biomarkers as an alternative to antibodies. Specifically, the paper focuses on the following aspects: 1. **Basic properties of aptamers**: The paper first introduces the structural characteristics of aptamers. They are single - stranded DNA or RNA molecules consisting of 20 to 100 nucleotides and are able to form complex three - dimensional structures, thereby achieving high - affinity and specific binding to specific target molecules. 2. **Advantages of aptamers**: The paper discusses in detail the advantages of aptamers over traditional bio - recognition elements (such as antibodies), including easy synthesis, cost - effectiveness, renewable use, and the ability to carry out a variety of chemical modifications to meet different application requirements. 3. **Selection and design of aptamers**: The paper explores the process of selecting and designing aptamers through the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) method. SELEX is an in vitro screening technique that can screen out aptamers with high affinity and specificity from a randomly synthesized nucleic acid library. 4. **Applications of aptamers**: The paper also analyzes the potential advantages and applications of aptamers in various diagnostic techniques, with particular attention to quartz crystal microbalance (QCM) aptamer sensors and their combination with ELISA (Enzyme - Linked Immunosorbent Assay) methods. 5. **Challenges faced**: Although aptamers have many advantages, the paper also points out some challenges in current research. For example, it is necessary to understand the relationship between the structure of aptamers and their binding ability through bioinformatics methods in order to achieve targeted design for specific targets. Overall, this paper attempts to provide a comprehensive perspective, summarizing the latest knowledge and applications, especially emphasizing the potentially revolutionary impact of aptamers in the field of diagnosis.